TW200815009A - Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof - Google Patents

Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof Download PDF

Info

Publication number
TW200815009A
TW200815009A TW095130323A TW95130323A TW200815009A TW 200815009 A TW200815009 A TW 200815009A TW 095130323 A TW095130323 A TW 095130323A TW 95130323 A TW95130323 A TW 95130323A TW 200815009 A TW200815009 A TW 200815009A
Authority
TW
Taiwan
Prior art keywords
alkyl
group
compound
heteroaryl
aryl
Prior art date
Application number
TW095130323A
Other languages
English (en)
Chinese (zh)
Inventor
Gary T Emmons
Sathapana Kongsamut
Craig N Karson
Corinne M Legoff
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of TW200815009A publication Critical patent/TW200815009A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
TW095130323A 2005-08-19 2006-08-18 Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof TW200815009A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70965505P 2005-08-19 2005-08-19

Publications (1)

Publication Number Publication Date
TW200815009A true TW200815009A (en) 2008-04-01

Family

ID=37772166

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095130323A TW200815009A (en) 2005-08-19 2006-08-18 Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof

Country Status (17)

Country Link
US (1) US7618650B2 (cg-RX-API-DMAC7.html)
EP (1) EP1928442B1 (cg-RX-API-DMAC7.html)
JP (1) JP2009504761A (cg-RX-API-DMAC7.html)
KR (1) KR20080038416A (cg-RX-API-DMAC7.html)
CN (1) CN101242819A (cg-RX-API-DMAC7.html)
AR (1) AR055609A1 (cg-RX-API-DMAC7.html)
AT (1) ATE447400T1 (cg-RX-API-DMAC7.html)
AU (1) AU2006283703A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0614943A2 (cg-RX-API-DMAC7.html)
CA (1) CA2617980A1 (cg-RX-API-DMAC7.html)
DE (1) DE602006010219D1 (cg-RX-API-DMAC7.html)
ES (1) ES2336142T3 (cg-RX-API-DMAC7.html)
MX (1) MX2008001778A (cg-RX-API-DMAC7.html)
RU (1) RU2008110498A (cg-RX-API-DMAC7.html)
SG (1) SG140147A1 (cg-RX-API-DMAC7.html)
TW (1) TW200815009A (cg-RX-API-DMAC7.html)
WO (1) WO2007024600A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2889811B1 (fr) * 2005-08-19 2009-10-09 Sanofi Aventis Sa Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte, composition pharmaceutique la contenant et son application en therapeutique.
BRPI0520797B8 (pt) * 2005-11-18 2021-05-25 Accu Break Tech Inc forma de dosagem farmacêutica comprimida em bicamadas
WO2010045190A1 (en) 2008-10-15 2010-04-22 Boehringer Ingelheim International Gmbh Fused heteroaryl diamide compounds useful as mmp-13 inhibitors
EP2340243B1 (en) 2008-10-17 2014-10-08 Boehringer Ingelheim International GmbH Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
CN102018681A (zh) * 2010-12-10 2011-04-20 荣港生技医药科技(北京)有限公司 一种美乐托宁缓释剂、其制备方法及其应用
US20130060052A1 (en) * 2011-01-17 2013-03-07 Takeda Pharmaceutical Company Limited Orally dispersible tablet
CA2903394C (en) 2013-03-14 2021-08-31 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
US9120757B2 (en) 2013-03-14 2015-09-01 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
JP7792730B2 (ja) * 2022-04-27 2025-12-26 杭州新元素▲薬▼▲業▼有限公司 尿酸を降下させるために使用できる化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU726447B2 (en) * 1996-10-21 2000-11-09 Neurosearch A/S 1-phenyl-benzimidazole compounds and their use as BAGA-A receptor modulators
US20040258750A1 (en) * 1999-06-28 2004-12-23 Gerard Alaux Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
IL152411A0 (en) * 2000-04-24 2003-05-29 Teva Pharma Zolpidem hemitartrate
GT200600042A (es) * 2005-02-10 2006-09-27 Aventis Pharma Inc Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a

Also Published As

Publication number Publication date
EP1928442A2 (en) 2008-06-11
CA2617980A1 (en) 2007-03-01
ATE447400T1 (de) 2009-11-15
RU2008110498A (ru) 2009-09-27
ES2336142T3 (es) 2010-04-08
MX2008001778A (es) 2008-04-07
US7618650B2 (en) 2009-11-17
SG140147A1 (en) 2008-03-28
US20080138413A1 (en) 2008-06-12
WO2007024600A2 (en) 2007-03-01
EP1928442B1 (en) 2009-11-04
CN101242819A (zh) 2008-08-13
DE602006010219D1 (de) 2009-12-17
KR20080038416A (ko) 2008-05-06
AR055609A1 (es) 2007-08-29
AU2006283703A1 (en) 2007-03-01
BRPI0614943A2 (pt) 2011-04-26
JP2009504761A (ja) 2009-02-05
WO2007024600A3 (en) 2007-05-24

Similar Documents

Publication Publication Date Title
JP5419355B2 (ja) 選択的な5ht2aアンタゴニストとしての置換されたビスアリールおよびヘテロアリール化合物
CA3127854A1 (en) Methods and compositions comprising a 5ht receptor agonist for the treatment of psychological, cognitive, behavioral, and/or mood disorders
EP2217073B1 (en) Method of treating metabolic disorders and depression with dopamine receptor agonists
US7618650B2 (en) Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof
KR100845450B1 (ko) 약학적 제형물로서의 세로토닌 아고니스트 (5에이치티2)및 안타고니스트 (5에이치티6) 의 새로운 조합
TW200303199A (en) Novel pyridin-and pyrimidin-derivatives
TW520366B (en) Arylpiperazines having activity at the serotonin 1A receptor
HUP0103408A2 (hu) Dopamin-újrafelvétel inhibitorokat tartalmazó kompozíciók és az inhibitorok alkalmazási eljárásai
JP2003063994A (ja) アルツハイマー病およびパーキンソン病に関連する痴呆または認識障害のための組合せ治療
EP4658265A1 (en) 5-methoxy-n,n-dimethyltryptamine for the treatment of postpartum depression
EP0759299A1 (en) Potentiation of serotonin response
JP2008543782A (ja) 5−ht1a受容体のピペラジン−ピペリジンアンタゴニストおよびアゴニスト
JP2026513655A (ja) フェネチルアミン化合物、組成物、及び使用方法
AU2018356556A1 (en) New alcoxyamino derivatives for treating pain and pain related conditions
JP2008255064A (ja) 睡眠障害予防治療剤
US20080139615A1 (en) Combination of a hypnotic agent and r (+)-alpha-(2,3-dimethoxy-phenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol and therapeutic application thereof
TW200846032A (en) Sustained-release tablet formulations of piperazine-piperidine antagonists and agonists of the 5-HT1A receptor having enhanced intestinal dissolution
HK1121673A (en) Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof
JPH07503240A (ja) 3‐アリールインドールおよび1‐アリールインダゾール誘導体の精神病の治療のための使用
HK1123500A (en) Comination of a hypnotic agent and r(+)-alpha-(2,3-dimethoxy-phenyl)-1-[2-(4-fluorophenl)ethyl]-4-piperidinemethanol and therapeutic application thereof
JP2006503870A (ja) 睡眠障害の処置のための5−ht2受容体拮抗薬の使用
HK1057536B (en) New combination of serotonin agonist (5ht2) and antagonist (5ht6) as pharmaceutical formulation
HK1013797A (en) Potentiation of drug response by a serotonin 1a receptor antagonist